- Mission & Goals
- Working Groups
- Convener’s Corner
- Partners & Allies
- Photo Gallery
Former Presidents of Colombia, Mexico, and Switzerland together with Sir Richard Branson, US Former Federal Reserve Chair Paul Volcker and members of the Global Commission on Drug Policy call for reducing the harms caused by failed drug policy
Press conference also available here via LiveStream: www.globalcommissionondrugs.
(New York, NY) — On Thursday April 21 – the last day of the United Nations General Assembly Special Session (UNGASS) on drugs – several members of the Global Commission on Drug Policy will hold a press conference in New York. The Global Commission will evaluate the outcome of the UN meeting and call for concrete steps to ensure more effective drug policy reform in the years ahead. The UNGASS is taking place in New York from April 19-21 and is the first such gathering of governments in 18 years.
“Globally, we’re wasting too much money and precious resources on criminalizing people and sending them to jail when we should be spending this money on helping people – through proper medical care and education,” said Global Commission Member Sir Richard Branson. “From the perspective of an investor, the war on drugs has failed to deliver any returns. If it were one of my businesses, I would have shut it down many many years ago.”
Commissioner and former President of Switzerland, Ruth Dreifuss also notes that “many countries are already successfully adopting innovative harm reduction and treatment strategies such as needle exchange, substitution therapies, heroin prescription and safe consumption rooms”. She adds that “for these efforts to be truly effective, governments must decriminalize the use of drugs for personal use.”
WHAT: Live press conference with leaders of the Global Commission on Drug Policy. LiveStreaming will also be available here: www.globalcommissionondrugs.
WHEN: Thursday, April 21, 08.30am EDT. Breakfast and coffee available starting at 8am.
WHERE: Grand Hyatt New York, 109 E 42nd St, NYC, 10017, “Alvin + Carnegie” Rooms on the CC level.
• Ernesto Zedillo, Former President of Mexico
• César Gaviria Trujillo, Former President of Colombia
• Richard Branson, Entrepreneur, founder of the Virgin Group, cofounder of The Elders, UK
• Paul Volcker, Former Chairman of the US Federal Reserve and the Economic Recovery Board, U.S.
• Louise Arbour, Former UN High Commissioner for Human Rights, Canada
• Michel Kazatchkine, professor of medicine, former executive director of the Global Fund to fight AIDS, tuberculosis and malaria
• Nick Clegg, Former Deputy Prime Minister of the UK
• Pavel Bém, Former Mayor of Prague, Czech Republic
• Ruth Dreifuss, Former President of Switzerland
The Global Commission is urging the United Nations and all member states to adopt a people-centered approach to drug policy. This means putting health, safety and human rights first. Drawing on evidence-based policies from around the world, the Commission is calling on governments to:
• End the criminalization and incarceration of drug users;
• Abolish capital punishment for drug-related offenses;
• Empower the World Health Organization (WHO) to review the scheduling system of drugs on the basis of scientific evidence;
• Ensure a broad spectrum of treatment for dependent people and services designed to reduce the harms of drugs; and
• Develop, test and implement different approaches to drug regulation
in order to maximize public health and disempower organized crime.
The Global Commission believes the international drug policy regime has failed to achieve its original (and unrealistic) objectives of eradicating drug production and consumption. It has also generated alarming social, economic, political and health problems around the world. As former Presidents of Brazil, Colombia and Mexico noted in a recent Los Angeles Times op-ed: “outdated drug policies around the world have resulted in soaring drug-related violence, overstretched criminal justice systems, runaway corruption and mangled democratic institutions.”
Over the past two decades many countries have started taking matters into their own hands. For example, Switzerland opened safe consumption rooms and offers maintenance and heroin assisted therapy in order to allow users to have a more healthy and balanced life. Portugal decriminalized the use of all drugs in 2001, with significant crime prevention and public health benefits including decreasing rates of HIV. Cannabis clubs have sprung-up around parts of Spain, and Uruguay has regulated its cannabis market from production, to distribution and sale.
Meanwhile, the U.S. is pioneering different approaches to regulating marijuana. Already 23 states plus Washington, D.C. have regulated marijuana for medicinal purposes; and four states (together with Washington, D.C). have regulated marijuana for recreational purposes. There is now unprecedented debate among elected officials, including President Obama, about how to transform drug policies to reduce mass incarceration in the U.S. What is more, Canada and Mexico are also exploring the regulation of marijuana for medical and personal use, driven in large part by high-levels of violence and favorable public opinion.
ABOUT THE GLOBAL COMMISSION ON DRUG POLICY
Founded in 2011, the Global Commission on Drug Policy is composed of political leaders and intellectuals from around the world including: the former Presidents of: Brazil, Mexico, Colombia, Chile, Portugal, Switzerland, Nigeria, Greece and Poland; former UN Secretary General Kofi Annan; former U.S. Secretary of State George Shultz; entrepreneur Sir Richard Branson; former Chairman of the U.S. Federal Reserve Paul Volcker; former Canadian Supreme Court Justice Louise Arbour; as well as leaders from Czech Republic, India, Norway, Pakistan, Peru, Spain and the UK.
The Global Commission made international headlines when it came out in support of decriminalization in 2011. In 2014, the Commission released a ground-breaking report that highlighted five pathways to effective drug policies including: harm reduction measures; equitable access to controlled medicines; decriminalization of people who use or possess drugs; alternatives to incarceration for low-level participants in illicit drug markets, and experiments in legally regulating markets of currently illicit drugs. Since its founding the Global Commission has produced five major reports and three internationally acclaimed films.